Enterprise Value
65.51M
Cash
228.5M
Avg Qtr Burn
-24.31M
Short % of Float
13.10%
Insider Ownership
10.83%
Institutional Own.
73.20%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CB-011 Details Blood cancer, Cancer, Multiple myeloma | Phase 1 Data readout | |
CB-010 Details Non-Hodgkin lymphoma, Cancer, Blood cancer | Phase 1 Data readout |